<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="96956">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01842568</url>
  </required_header>
  <id_info>
    <org_study_id>VISION Cardiac Surgery</org_study_id>
    <nct_id>NCT01842568</nct_id>
  </id_info>
  <brief_title>Vascular Events In Surgery patIents cOhort evaluatioN - Cardiac Surgery</brief_title>
  <official_title>Vascular Events In Surgery patIents cOhort evaluatioN - Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Population Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Abbott Diagnostics Division</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Population Health Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Worldwide over 2 million adults (&gt;30,000 Canadians) undergo heart surgery annually. Although
      heart surgery provides important survival benefits, it is associated with potential major
      complications such as death, stroke, and heart attack. There is promising evidence that
      measurement of heart injury markers after surgery will identify patients at risk of death or
      major complications.

      This study will determine the current incidence of major complications in a representative
      sample of 15,000 contemporary adult patients undergoing heart surgery. Knowing the current
      burden of complications will inform clinicians, administrators, government and granting
      agencies about resources required to address the problem. This study will also establish the
      role of measuring heart injury markers to identify important heart injury after heart
      surgery and the proportion that would go undetected without routine heart injury marker
      monitoring. This information will facilitate further studies of timely interventions. In
      summary, the VISION Cardiac Surgery Study addresses fundamental questions that will have
      profound public health implications given the millions of adults worldwide who undergo heart
      surgery annually.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">July 2019</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>All-cause mortality at 30-days after surgery</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>All-cause mortality at 30-days after surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Myocardial injuries that were not identified clinically during the first 5 days after surgery</measure>
    <time_frame>5 days after surgery</time_frame>
    <description>Myocardial injuries that were not identified clinically during the first 5 days after surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Composite of vascular death, nonfatal myocardial infarction, nonfatal cardiac arrest, nonfatal stroke, and mechanical assist device</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Major vascular complications at 30 days after surgery (i.e., a composite of vascular death, nonfatal myocardial infarction, nonfatal cardiac arrest, nonfatal stroke, and mechanical assist device)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Composite of vascular death, nonfatal myocardial infarction, nonfatal cardiac arrest, nonfatal stroke, and mechanical assist device</measure>
    <time_frame>1 year after surgery</time_frame>
    <description>Major vascular complications at 1-year after surgery (i.e., a composite of vascular death, nonfatal myocardial infarction, nonfatal cardiac arrest, nonfatal stroke, and mechanical assist device)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Composite of vascular death, nonfatal myocardial infarction, nonfatal stroke, and mechanical assist device</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Major vascular complications at 30-days after surgery (i.e., a composite of vascular death, nonfatal myocardial infarction, nonfatal stroke, and mechanical assist device)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total mortality</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Total mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total mortality</measure>
    <time_frame>1 year after surgery</time_frame>
    <description>Total mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vascular mortality</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>death due to vascular cause</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vascular mortality</measure>
    <time_frame>1 year after surgery</time_frame>
    <description>death due to vascular cause</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial infarction</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Myocardial infarction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial infarction</measure>
    <time_frame>1 year after surgery</time_frame>
    <description>Myocardial infarction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non-fatal cardiac arrest</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Non-fatal cardiac arrest</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non-fatal cardiac arrest</measure>
    <time_frame>1 year after surgery</time_frame>
    <description>Non-fatal cardiac arrest</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke</measure>
    <time_frame>1 year after surgery</time_frame>
    <description>Stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Implantation of mechanical assist device</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Implantation of mechanical assist device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Implantation of mechanical assist device</measure>
    <time_frame>1 year after surgery</time_frame>
    <description>Implantation of mechanical assist device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac transplant</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Cardiac transplant</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac transplant</measure>
    <time_frame>1 year after surgery</time_frame>
    <description>Cardiac transplant</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Repeat cardiac revascularization procedures</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Repeat cardiac revascularization procedures</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Repeat cardiac revascularization procedures</measure>
    <time_frame>1 year after surgery</time_frame>
    <description>Repeat cardiac revascularization procedures</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Congestive heart failure</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Congestive heart failure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Congestive heart failure</measure>
    <time_frame>1 year after surgery</time_frame>
    <description>Congestive heart failure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>New atrial fibrillation</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>New clinically important atrial fibrillation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>New atrial fibrillation</measure>
    <time_frame>1 year after surgery</time_frame>
    <description>New clinically important atrial fibrillation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulmonary embolus</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Pulmonary embolus</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulmonary embolus</measure>
    <time_frame>1 year after surgery</time_frame>
    <description>Pulmonary embolus</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Deep venous thrombosis</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Deep venous thrombosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Deep venous thrombosis</measure>
    <time_frame>1 year after surgery</time_frame>
    <description>Deep venous thrombosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major bleeding</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Major bleeding</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major bleeding</measure>
    <time_frame>1 year after surgery</time_frame>
    <description>Major bleeding</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>New dialysis</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>New dialysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>New dialysis</measure>
    <time_frame>1 year after surgery</time_frame>
    <description>New dialysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infection</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Infection (including sternal, sepsis, pneumonia)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infection</measure>
    <time_frame>1 year after surgery</time_frame>
    <description>Infection (including sternal, sepsis, pneumonia)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Re-hospitalization for a vascular reason</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Re-hospitalization for a vascular reason</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Re-hospitalization for a vascular reason</measure>
    <time_frame>1 year after surgery</time_frame>
    <description>Re-hospitalization for a vascular reason</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chronic incisional pain</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Chronic incisional pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chronic incisional pain</measure>
    <time_frame>1 year after surgery</time_frame>
    <description>Chronic incisional pain</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">15000</enrollment>
  <condition>Vascular Death</condition>
  <condition>Myocardial Infarction</condition>
  <condition>Stroke</condition>
  <condition>Cardiac Surgery</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who have undergone cardiac surgery who are at least 18 years of age.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age ≥ 18 years.

          2. Patients who have undergone cardiac surgery. This includes coronary artery bypass
             grafting and all open heart procedures such as valvular repairs/replacement.

        Exclusion Criteria:

          1. Previously enrolled in the VISION Cardiac Surgery Study.

          2. Patients who have undergone an isolated pericardial window, pericardiectomy,
             permanent pacemaker or defibrillator implantation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>P.J. Devereaux, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>McMaster University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andre Lamy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>McMaster University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Valerie Dunlop</last_name>
    <phone>905-527-4322</phone>
    <phone_ext>40675</phone_ext>
    <email>valerie.dunlop@phri.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ronald Reagan Medical Centre, UCLA</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aman Mahajan, MD</last_name>
      <phone>310-267-8680</phone>
      <email>amahajan@mednet.ucla.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Prince Alfred Hospital</name>
      <address>
        <city>Sydney</city>
        <state>New South Wales</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Graham Hillis, M.D</last_name>
      <phone>+61293362699</phone>
      <email>ghillis@georgeinstitute.org.au</email>
    </contact>
    <investigator>
      <last_name>Graham Hillis, M.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hamilton Health Sciences</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8L 2X2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andre Lamy, MD</last_name>
      <phone>905-527-4322</phone>
      <phone_ext>40324</phone_ext>
      <email>lamya@mcmaster.ca</email>
    </contact>
    <contact_backup>
      <last_name>P.J. Devereaux, MD, PhD</last_name>
      <phone>905-527-4322</phone>
      <phone_ext>40654</phone_ext>
      <email>philipj@mcmaster.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Andre Lamy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Richard Whitlock, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kingston General Hospital</name>
      <address>
        <city>Kingston</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rene Allard, MD</last_name>
      <phone>(613) 549-6666</phone>
      <phone_ext>7827</phone_ext>
      <email>allardr@kgh.kari.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sunnybrook Health Sciences Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen Choi, MD</last_name>
      <phone>1-416-480-6100</phone>
      <phone_ext>4864</phone_ext>
      <email>stephen.choi@sunnybrook.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>First Teaching Hospital</name>
      <address>
        <city>XinJiang</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zheng Hong, MD</last_name>
      <phone>+86 13565996995</phone>
      <email>xjzhenghong@aliyun.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Prince of Wales Hospital</name>
      <address>
        <city>Shatin</city>
        <state>Hong Kong, SAR</state>
        <zip>NT</zip>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew Chan, MD</last_name>
      <phone>+852 2632 2736</phone>
      <email>mtvchan@cuhk.edu.hk</email>
    </contact>
    <contact_backup>
      <last_name>Beaker Fung</last_name>
      <phone>85226321905</phone>
      <email>beaker@cuhk.edu.hk</email>
    </contact_backup>
    <investigator>
      <last_name>Matthew Chan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Bari &quot;Aldo Moro&quot;</name>
      <address>
        <city>Bari</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Domenico Paparella, MD</last_name>
      <phone>00390805595076</phone>
      <email>domenico.paparella@uniba.it</email>
    </contact>
    <investigator>
      <last_name>Domenico Paparella, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Jantung Negara Sdn. Bhd.</name>
      <address>
        <city>Kuala Lumpur</city>
        <zip>50400</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suhaini Kadiman, MD</last_name>
      <phone>+603-26178522</phone>
      <email>suhaini@ijn.com.my</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Malaya Medical Centre</name>
      <address>
        <city>Kuala Lumpur</city>
        <zip>59100</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chew Yin Wang, MD</last_name>
      <email>wangcy@um.edu.my</email>
    </contact>
    <contact_backup>
      <last_name>Ching Yen Chong</last_name>
      <email>chingyen.chong@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Chew Yin Wang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Research Institute of Circulation Pathology</name>
      <address>
        <city>Novosibirsk</city>
        <zip>630055</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vladimir Lomivorotov, MD</last_name>
      <phone>7 (913) 916 41 03</phone>
      <email>vvlom@mail.ru</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <zip>08025</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>BHF Centre of Cardiovascular Science, University of Edinburgh</name>
      <address>
        <city>Edinburgh</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nick Mills, MD</last_name>
      <phone>+44 (0) 131 242 6515</phone>
      <email>nick.mills@ed.ac.uk</email>
    </contact>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Canada</country>
    <country>China</country>
    <country>Hong Kong</country>
    <country>Italy</country>
    <country>Malaysia</country>
    <country>Russian Federation</country>
    <country>Spain</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <lastchanged_date>October 4, 2016</lastchanged_date>
  <firstreceived_date>April 17, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Population Health Research Institute</investigator_affiliation>
    <investigator_full_name>Andre Lamy</investigator_full_name>
    <investigator_title>Professor and Cardiac Surgeon</investigator_title>
  </responsible_party>
  <keyword>Cardiac surgery</keyword>
  <keyword>Troponin</keyword>
  <keyword>Vascular events</keyword>
  <keyword>Myocardial injury</keyword>
  <keyword>Observational cohort study</keyword>
  <keyword>Public health</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
